Fresh Equities
Raises
Research
About
Looking for more information?

Contact our responsive and friendly client services team any time.

BIONOMICS LIMITED

INVESTOR PRESENTATION - BIONOMICS LIMITED

ASX:BNO

BIONOMICS LIMITED

Health Care

Bionomics Limited (BNO) is an Australian biopharmaceutical company focused on the discovery and development of cancer, central nervous system disorders such as anxiety, depression and Alzheimer's Disease. BNO partners with pharmaceutical companies to get the drugs through the later stages of development and into the market.

Read more

Market Cap

102.14m

Price at Close

$0.15

4w avg. Volume

1.13m

4w avg. Turnover

$177.98k

Announcements
announcementt+2 movementdate
  • BNO Successfully Completes Institutional Entitlement Offer

    Issued Capital · Market sensitive

  • -

    27 Sep 2020

-

27 Sep 2020
  • Initial Director's Interest Notice

    Shareholder Details

  • -16.67%

    25 Sep 2020

-16.67%

25 Sep 2020
  • Initial Director's Interest Notice

    Shareholder Details

  • -16.67%

    25 Sep 2020

-16.67%

25 Sep 2020
  • Proposed issue of Securities - BNO

    Issued Capital

  • -16.67%

    24 Sep 2020

-16.67%

24 Sep 2020
  • Appointment of Two New Directors

    Company Administration

  • -16.67%

    24 Sep 2020

-16.67%

24 Sep 2020
  • Equity Raising Notification to Option Holders

    Issued Capital

  • 0.00%

    23 Sep 2020

0.00%

23 Sep 2020
  • Cleansing Notice

    Issued Capital

  • 0.00%

    23 Sep 2020

0.00%

23 Sep 2020
  • Appendix 3B

    Issued Capital

  • 0.00%

    23 Sep 2020

0.00%

23 Sep 2020
  • Investor Presentation Pro Rata Entitlement Offer

    Periodic Reports · Market sensitive

  • 0.00%

    23 Sep 2020

0.00%

23 Sep 2020
  • BNO Announces Accelerated Non-Renounceable Entitlement Offer

    Issued Capital · Market sensitive

  • 0.00%

    23 Sep 2020

0.00%

23 Sep 2020
Market Data

Current Price

$0.15

52WK HIGH

$0.19

52WK LOW

$0.03

1YR RETURN

+11.11%

1YR RETURN VS. SECTOR

-23.44%

90 DAY RETURN

+158.62%

ASX RANK

760

/2,017

SECTOR RANK

14

/47

SHARES OUTSTANDING

680.94m
ASX:BNO

BIONOMICS LIMITED

Health Care

Bionomics Limited (BNO) is an Australian biopharmaceutical company focused on the discovery and development of cancer, central nervous system disorders such as anxiety, depression and Alzheimer's Disease. BNO partners with pharmaceutical companies to get the drugs through the later stages of development and into the market.

Read more

Market Cap

102.14m

Price at Close

$0.15

4w avg. Volume

1.13m

4w avg. Turnover

$177.98k

ASX:BNO is not raising right now

Want to invest?

Fresh Equities

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.

Contact Us

(03) 9028 2888

clients@freshequities.com

Address

Level 7, 388 Bourke St
Melbourne VIC 3000
Australia

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.